2018
DOI: 10.1093/neuros/nyy071
|View full text |Cite
|
Sign up to set email alerts
|

Liposclerosing Myxofibrous Tumor of the Cranial Vault: A Case Report

Abstract: LSMFT is a rare tumor that should remain on the differential for lesions of the calvarium. When diagnosed, this lesion can be removed with the goal of gross total resection and excellent cosmesis can be achieved.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…On T1weighted images, the signal intensity of the lesion was comparable to that of skeletal muscle. On T2-weighted images, the signal intensity is greater than that of fat owing to the presence of myxoid tissue, which can be easily distinguished from intraosseous lipoma (3,4,15). The histological compositions of this tumor are complex and may consist of a variety of histological structures in varying proportions, including lipoma, fibroxanthoma, myxoma, myxofibroma, fibrous tissue, cyst formation, fat necrosis, ischemic bone tissue, and rarely cartilaginous tissue (1,2,4,5,7).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…On T1weighted images, the signal intensity of the lesion was comparable to that of skeletal muscle. On T2-weighted images, the signal intensity is greater than that of fat owing to the presence of myxoid tissue, which can be easily distinguished from intraosseous lipoma (3,4,15). The histological compositions of this tumor are complex and may consist of a variety of histological structures in varying proportions, including lipoma, fibroxanthoma, myxoma, myxofibroma, fibrous tissue, cyst formation, fat necrosis, ischemic bone tissue, and rarely cartilaginous tissue (1,2,4,5,7).…”
Section: Discussionmentioning
confidence: 99%
“…Liposclerosing myxofibrous tumor (LSMFT) was first described by Ragsdale and Sweet in 1986 (1). It is a relatively uncommon benign bone tumor that may arise in the proximal femur and other parts such as the ilium, humerus, tibia, ribs, and skull (1)(2)(3)(4)(5). The condition generally manifests itself around 40 years old, and the reported onset age is between 15 and 80 years old, with no notable gender difference (1)(2)(3)6).…”
Section: Introductionmentioning
confidence: 99%
“…Liposclerosing myxofibrous tumors (LSMFT) are rare, benign fibro-osseous lesions commonly occurring in the femoral intertrochanteric region. It can also be seen occasionally at other sites such as humerus, rib, iliac bone (Kransdorf et al, 1999;Ragsdale, 1993), tibia (Choi et al, 2005;Regado et al, 2016) and skull (Ploof et al, 2018). The reason for this strong predilection is unknown.…”
Section: Discussionmentioning
confidence: 99%